From a genome-wide screen, a prominent observation after genetic ablation of IGF1 receptor in AD mice is the reduction in expression level of NEFM, down to control level, suggesting that lower-abundance of NEFM is protective46. This evidence concerns the gene NEFM and Alzheimer disease.